Laurent Ramont

Control of melanoma cell invasion by type IV collagen.

[A very curious electrophoresis].

Effects of hemolysis and storage condition on neuron-specific enolase (NSE) in cerebrospinal fluid and serum: implications in clinical practice.

Structural and antitumor properties of the YSNSG cyclopeptide derived from tumstatin.

The NC1 domain of type XIX collagen inhibits in vivo melanoma growth.

The YSNSG cyclopeptide derived from tumstatin inhibits tumor angiogenesis by down-regulating endothelial cell migration.

The NC1 domain of type XIX collagen inhibits melanoma cell migration.

Tetrastatin, the NC1 domain of the α4(IV) collagen chain: a novel potent anti-tumor matrikine.

[Recommendations for the management of monoclonal gammopathies in biochemistry].

Matrikines from basement membrane collagens: a new anti-cancer strategy.

Endostatin level in cerebrospinal fluid of patients with Alzheimer's disease.

Plasmin releases the anti-tumor peptide from the NC1 domain of collagen XIX.

The anti-tumor NC1 domain of collagen XIX inhibits the FAK/ PI3K/Akt/mTOR signaling pathway through αvβ3 integrin interaction.

Milky Pleural Fluid.

Modifications to bicarbonate conductivity: A way to increase phosphate removal during hemodialysis? Proof of concept.

Aging decreases collagen IV expression in vivo in the dermo-epidermal junction and in vitro in dermal fibroblasts: possible involvement of TGF-β1.

Type XIX collagen: A new partner in the interactions between tumor cells and their microenvironment.

Evaluation of Lumipulse® G1200 for the measurement of six tumor markers: Comparison with AIA® 2000.

Confusing Hyperkalemia.

Tau protein as a possible marker of cerebrospinal fluid leakage in cerebrospinal fluid rhinorrhoea: A pilot study.

Structural characterization and pro-tumor properties of a highly conserved matrikine.

Conformation-dependent binding of a Tetrastatin peptide to αβ integrin decreases melanoma progression through FAK/PIK/Akt pathway inhibition.

Tumour cell blebbing and extracellular vesicle shedding: key role of matrikines and ribosomal protein SA.

Tumor Microenvironment: Extracellular Matrix Alterations Influence Tumor Progression.

Angiogenesis Inhibition by a Short 13 Amino Acid Peptide Sequence of Tetrastatin, the α4(IV) NC1 Domain of Collagen IV.

Extracellular Vesicle-Dependent Cross-Talk in Cancer-Focus on Pancreatic Cancer.

Hair Histology and Glycosaminoglycans Distribution Probed by Infrared Spectral Imaging: Focus on Heparan Sulfate Proteoglycan and Glypican-1 during Hair Growth Cycle.

Lack of admission biomarkers' clinical utility in outcomes prediction in patients suspected with infection in the emergency department.

Analysis of 1635 procalcitonin prescriptions in the emergency department of a university hospital: A gap between evidence-based medicine and the real world?

Clinical Outcome Predictive Value of Procalcitonin in Patients Suspected with Infection in the Emergency Department.

F4, a collagen XIX-derived peptide, inhibits tumor angiogenesis through αvβ3 and α5β1 integrin interaction.

Differential MMP-14 Targeting by Lumican-Derived Peptides Unraveled by In Silico Approach.

Assessment of Ovarian Tumor Growth in Wild-Type and Lumican-Deficient Mice: Insights Using Infrared Spectral Imaging, Histopathology, and Immunohistochemistry.

The Glypican-1/HGF/C-Met and Glypican-1/VEGF/VEGFR2 Ternary Complexes Regulate Hair Follicle Angiogenesis.

Increased intravitreal glucose in rhegmatogenous retinal detachment.

Association between admission biomarkers and clinical outcome in older adults diagnosed with an infection in the emergency department.

Differential MMP-14 Targeting by Biglycan, Decorin, Fibromodulin and Lumican Unraveled by In Silico Approach.

Regulation of stem cell fate by HSPGs: implication in hair follicle cycling.